Transcatheter Interventions Online 2024 - On Demand

Published: 20 March 2024

  • Views:

    Views Icon 2802
  • Likes:

    Heart Icon 7
  • episode_image
    Now Playing
    Part 2 | Session 6 of 6
    Day Two Close
    Roxana Mehran
    Up Next
  • episode_image
    58m 49s
    Part 2 | Session 4 Session 2.3: Imaging Focus Roxana Mehran, Joost Daemen, David Hildick-Smith, Ajay J Kirtane, Natalia Pinilla
Average (ratings)
No ratings
Your rating

Overview

TIO 2024 brought together an outstanding international faculty, creating an unparalleled interactive experience that will keep the global interventional cardiology community up-to-date with the latest advancements in transcatheter treatment strategies. Featuring a combination of expert opinions, engaging discussions, insightful presentations and live cases from prominent medical centres on both sides of the Atlantic, TIO delivered the highest-quality CME-accredited education.

 

 

 

Related Content:

 

Key Learning Objectives

  • Review planning and valve selection strategies in patients with prior valve failure
  • Summarise recent repair and replacement data in mitral and tricuspid regurgitation
  • Select suitable tools for undertaking PCI in calcified lesions
  • Optimise use of imaging in daily practice
  • Outline the pros and cons of using P2Y12 inhibitors universally following PCI
  • Identify situations where an IVUS or OCT-guided approach are preferable
  • Discuss the possible implications of TAVR becoming a care option in asymptomatic aortic stenosis

Target Audience

  • Interventional Cardiologists
  • Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
  • Interventional Cardiology Nurses

More from this programme

Faculty Biographies

Roxana Mehran

Roxana Mehran

Professor of Medicine, Cardiology and Professor of Population Health Science and Policy

Roxana Mehran is Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai in New York. She is also Director of Interventional Cardiovascular Research and Clinical Trials at The Zena and Michael A Weiner Cardiovascular Institute at Mount Sinai Hospital where, over the past 5 years, she has led the development of a globally respected data and clinical coordination centre to support large, multicentre, multinational clinical trials designed to help improve outcomes and quality of life for patients undergoing interventional cardiovascular procedures. In recent years, her work has had a special emphasis on gaining a deeper understanding of anticoagulation and antiplatelet regimens post angioplasty and transcatheter valve replacement; and collection and interpretation of sex-specific data in cardiovascular clinical trials.

Roxana serves on editorial board of multiple peer reviewed journals, including …

View full profile

Comments

You must be to comment. If you are not registered, you can register here.